In case you missed it: Oct. 25 to Oct. 29
Here's what you missed this week on Contemporary OB/GYN®.
This week's top articles included:
Pregnancy outcomes vary in women with psoriatic arthritis
The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
Pregnancy outcomes vary in women with psoriatic arthritis
The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
Menopause preparedness for patient, provider, and policymaker
A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.
Supreme Court to review Texas abortion law
The U.S. Supreme Court has agreed to review Texas’ controversial abortion ban on Nov. 1. However, they refused to block the law during the examination process, during which they will decide whether the Department of Justice has the right to sue to block the law.
Phase 1 trial launched investigating vaccine for triple-negative breast cancer
Preclinical data shows this investigational vaccine’s potential in preventing triple-negative breast cancer and inhibiting existing tumor growth.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
